mfrancy

🚨 Does TP53 status overshadows the prognostic significance of HPV in penile cancer patients? ❗️Read all about it in the first single-cell RNA sequencing atlas of penile cancer: authors.elsevier.com/a/1i%7Elg14kpl… @EUplatinum Let’s go on a biological journey through this paper:🧵(1/9)

“Ten years ago I was kicked out and forced to retire.” Our new medicine laureate Katalin Karikó (@kkariko) told us how much it means to be awarded the Nobel Prize after a scientific career that has been full of challenges. Ten years ago, Karikó was still doing all her experiments by hand but today she has been awarded the medicine prize for her research on mRNA, which led to the development of COVID-19 vaccines. Listen now:

En als je meer wil weten over partnergeweld raad ik aan je te verdiepen in hoe ‘coercive control’, oftewel dwingende controle werkt.

Our book chapter on the use of humanised mice for anti-cancer therapy is freely available for 50 days here 👇🏼 authors.elsevier.com/a/1hj-K,25QIop…

A nice article explaining the rational behind the use of tetracyclines for the treatment of #melanoma with limited therapeutic options. @LeucciLRCB stories.kuleuven.be/en/stories/ant…

#EMBOnoncodingRNA speaker #3 👩‍💼We are excited to introduce Prof. Eleonora Leucci (@LeucciLRCB) 🧬Prof Leucci's group (LRCB) at @KU_Leuven explore the role of lncRNAs in cancer and how they contribute to therapeutic resistance, while also leveraging essential lncRNAs for therapy

📰 Targeting Post-Translational Modifications in Lung Cancer 🔍 Lung cancer is one of the most common cancers. It consists of two different subtypes: non-small cell lung cancer and small cell lung cancer. 👨‍🎓 Maria Francesca Baietti , Raj Nayan Sewduth 🔗 encyclopedia.pub/entry/39897

Glad to see this work out! Enjoy the reading

Delighted to share the work the lab of the past 5 years. We found that in response to the ISR, the primate-specific #lncRNA LISR customises the #ribosomes to drive translation of an immune suppressive signature biorxiv.org/content/10.110…

now online with ⁦@RajSewduth⁩ mdpi.com/1999-4923/15/1…

To close this year, the December cover of Cancer Research is dedicated to our work on the lncRNA LENOX. Congrats to the multitalented Giovanni Gambi not on Twitter for the design!

✨ As the end of the year is coming, the TRACE PDX platform team thanks you for your loyalty and wishes you joyous holidays and a 2023 full of success ✨ #team #success #kuleuven

😍😍

Expanding the HDAC druggable landscape beyond enzymatic inhibition biorxiv.org/content/10.110…

#thisisbelgium #justitie ringtv.be/nieuws/werkstr…

A box full of happiness 😍

Collaboration with UGent on tumour-derived extracellular RNA is now out! | NAR Cancer | Oxford Academic academic.oup.com/narcancer/arti…

Vandaag vieren we overal in Vlaanderen Dag van de Wetenschap! 🧑‍🔬 Zoek je favoriete activiteit en leer meer over kankeronderzoek op verschillende locaties in Leuven, Gent, Brussel en Antwerpen #DVDW2022 👉dagvandewetenschap.be/activiteiten?p…

Happy to share this new study led by Sebastian Corre and Marie-Dominique Galibert lab where our PDX models have been used to demonstrate that inhibitors of SRC re-sensitize melanoma to BRAFi